Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
NPJ Biofilms and Microbiomes
|
February 19, 2026
Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa
Vanessa Croatti, Caroline Dricot, Tom Eilers, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 5, 2021
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
Vladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, et al.
European Journal of Medicinal Chemistry
|
September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
Giselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, et al.
Journal of Medicinal Chemistry
|
March 10, 2022
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Sandra Codony, Caterina Pont, Christian Griñán-Ferré, et al.
British Journal of Pharmacology
|
January 26, 2026
Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking
Shams T Osman, Perihan A Elzahhar, Md Abdul Hakim, et al.
European Journal of Medicinal Chemistry
|
August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
Paola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
ACS Pharmacology & Translational Science
|
June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction
Perihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
European Journal of Medicinal Chemistry
|
May 26, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction
Nayera W Hassan, Ola S Afifi, Maryam A Z El-Attar, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
NPJ Biofilms and Microbiomes
|
February 19, 2026
Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa
Vanessa Croatti, Caroline Dricot, Tom Eilers, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 5, 2021
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
Vladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, et al.
European Journal of Medicinal Chemistry
|
September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
Giselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, et al.
Journal of Medicinal Chemistry
|
March 10, 2022
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Sandra Codony, Caterina Pont, Christian Griñán-Ferré, et al.
British Journal of Pharmacology
|
January 26, 2026
Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking
Shams T Osman, Perihan A Elzahhar, Md Abdul Hakim, et al.
European Journal of Medicinal Chemistry
|
August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
Paola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
ACS Pharmacology & Translational Science
|
June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction
Perihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
European Journal of Medicinal Chemistry
|
May 26, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction
Nayera W Hassan, Ola S Afifi, Maryam A Z El-Attar, et al.
Page
of 7